News
Aramco pumped more oil but lower prices hurt its top line as crude on average fell to $66.7 a barrel from $76.3 earlier this ...
Defense contractor Leidos Holdings raised its full-year adjusted profit forecast on Tuesday, as demand for its technical ...
By Hakan Ersen and Miranda Murray BERLIN (Reuters) -German chipmaker Infineon slightly raised its full-year profit guidance ...
Caterpillar reported a lower second-quarter profit on Tuesday due to sluggish construction equipment demand and warned of up ...
The write-down of Berkshire Hathaway's 27.4% stake in Kraft Heinz, its second for the company, reflects a significant decline ...
Amazon is entering a new phase of margin expansion, driven by core retail rather than just AWS and advertising. Click here to ...
Alembic Pharmaceuticals posts 14% Y-o-Y rise in Q1 profit to ₹154 crore and 10% revenue growth, driven by volume gains and ...
The telehealth-consultation platform posted an increase in profit and revenue for the second quarter on growth in subscribers ...
The $3.00-a-share midpoint of its new range would put it just below the FactSet consensus estimate of $3.02 a share for Pfizer’s adjusted 2025 earnings.
Investors will find a few items of interest in Saturday’s quarterly report from Warren Buffett’s conglomerate.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results